The vaccine was well tolerated,and 1/2 placebo vaccines who acquired EBV developed infectious mononucleosis. Single-epitope vaccination did not predispose individuals to disease, nor did it significantly influence development of a normal repertoire of EBV specific CD8(+) T-cell responses following seroconversion (62). The gene discussed is CD8A; the disease is infectious mononucleosis.